Filter:
Wave Life Sciences recently hosted Alpha Dan Coffin and his wife Kathi at their offices to speak with employees about […]
“This model gives us the ability to study injury to liver cells resulting from both MZ and ZZ genotypes. This […]
Week #4 of the Virtual Walk has come to an end… and the feeling of THANKFULNESS for the Alpha-1 community […]
Read More… from November Alpha-1 Awareness Month: Week 4 Recap
It is with great sadness that we share the news that AlphaNet Coordinator Doug Turley passed away on November 22, […]
Read More… from The Alpha-1 Community Mourns the Loss of Veteran AlphaNet Coordinator Doug Turley
Week 3 for the Virtual Walk was a huge success! We had many individual walkers from across the country out […]
Congratulations to Rob Ploke who submitted Kangchenjunga the third-highest mountain in the world at 28,169 feet. Rob, a longtimefriend of […]
The second week of the Alpha-1 Virtual Walks was a huge success! We are officially at the halfway mark of […]
Read More… from Week 2 Recap: Let’s Cure It! Alpha-1 Awareness Month
FOR IMMEDIATE RELEASE November 10, 2022- The Alpha-1 Foundation announces the appointment of Andrew A. Wilson, MD as its new […]
Read More… from Announcing Andrew A. Wilson MD as the Alpha-1 Foundation’s new Scientific Director
November is finally here and with it comes cooler temperatures, autumn scenery, and most importantly, Alpha-1 Awareness Month! On November […]
Grifols receives FDA clearance for AlphaID™ At Home, the first free service for U.S. consumers to determine their risk for […]
Read More… from Grifols receives FDA clearance for AlphaID™ At Home
– Initiates first-in-human trial of next-wave AAT corrector, VX-634 – Phase 2 study evaluating the impact of longer-term treatment with VX-864 to […]
Read More… from Vertex Advances Program Targeting Alpha-1 Antitrypsin Deficiency
TUCSON, Ariz., Oct. 6, 2022 — Critical Path Institute (C-Path) today announced that it has recently launched a pre-consortium collaboration […]
Following a successful September Advocacy Workshop in Washington DC, the Alpha-1 Foundation has gained significant momentum on the advocacy front, […]
Read More… from How to Make an Impact by Getting Involved in Alpha-1 Advocacy
“The Alpha-1 Foundation is pleased with the FDA’s indication of a potential for accelerated approval of INHBRX -101. A1F values […]
Read More… from Inhibrx Shares Jump Premarket After Talks With FDA on INBRX-101
FOR IMMEDIATE RELEASE In honor of their father’s 80th birthday, Donald Helms Jr. and Donna Flowers are determined to spread […]
Read More… from Raising Alpha-1 Awareness at Drive-In Movie Night
FOR IMMEDIATE RELEASE September 30, 2022- Paul Kosak will be climbing Mount Kilimanjaro an epic adventure starting October 15th with […]
FOR IMMEDIATE RELEASE September 23, 2002- The Alphas are headed to the Cape Cod, Massachusetts this weekend for the annual […]
Alpha-1 patient advocates, Foundation staff, and industry representatives ascended to Capitol Hill to partake in the 2022 Alpha-1 Advocacy Workshop […]
The Alpha-1 Foundation is sad to announce that Laura Pearson passed away on September 11, 2022. Laura was a part […]
September 19, 2022 The Hon. Patrick Leahy The Hon. Richard Shelby Chairman Vice Chairman Senate Committee on Appropriations Senate Committee […]
WASHINGTON — The Food and Drug Administration authorized the first redesign of coronavirus vaccines since they were rolled out in late […]
Read More… from F.D.A. Authorizes Updated Covid Booster Shots Targeting Omicron Subvariants
The Alpha-1 Foundation and undersigned pulmonary organizations and patient advocacy groups have provided comments on the CY 2023 update to […]
Deb Labud of Gainesville, Florida looks forward to attending the bi-yearly transplant games and was excited to get back in […]
August 11, 2022 –– Today, CDC is streamlining its COVID-19 guidance to help people better understand their risk, how to […]
